Cidara Therapeutics
CDTX
NASDAQ
IPO2015
about CDTX
Cidara Therapeutics develops innovative medicines focused on treating infections and cancers through its research in infectious disease and oncology.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $217.20 | $218.85 | $216.80 | $6.84B | 17.29M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$3.10 | n/a | n/a | 0% | 0% | 0% |